Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Courtney D. DiNardo | Researchclopedia

Back to researchers

Courtney D. DiNardo

The University of Texas MD Anderson Cancer Center ORCID

1,582

Works

47,916

Citations

94

h-index

505

i10-index

Research Topics

Acute Myeloid Leukemia Research Chronic Myeloid Leukemia Treatments Myeloproliferative Neoplasms: Diagnosis and Treatment

Affiliations

Liechtenstein Institute2023–2023

Boston Children's Hospital2023–2023

Albert Einstein College of Medicine2025–2025

Hudson Institute2016–2023

Mayo Clinic2023–2023

Top Works

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

Hartmut Döhner,Andrew H. Wei,et al.

20222,799 citations

Acute Lymphoblastic Leukemia research

Histone Deacetylase Inhibitors Research

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

Courtney D. DiNardo,Brian A. Jonas,et al.

20202,668 citations

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Daniel A. Arber,Attilio Orazi,et al.

20222,499 citations

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

Courtney D. DiNardo,Keith W. Pratz,et al.

20181,826 citations

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

Eytan M. Stein,Courtney D. DiNardo,et al.

20171,448 citations

Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML

Courtney D. DiNardo,Eytan M. Stein,et al.

20181,383 citations

Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia

Marina Konopleva,Daniel A. Pollyea,et al.

20161,040 citations

Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial

Andrew H. Wei,Pau Montesinos,et al.

2020734 citations

Acute myeloid leukemia: current progress and future directions

Hagop M. Kantarjian,Tapan M. Kadia,et al.

2021733 citations